11/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

11/09/2024

Sep 11, 2024, 16:47 | Blog
Chandler Park: Informative talk by Hiba Khan on the PARP inhibitor combination trials
Chandler Park shared a post on X: "Loved this informative talk by Dr. Hiba Khan,…
Sep 11, 2024, 16:34 | Insight
Andrea Necchi: Our next piece of the neoadjuvant puzzle in muscle-invasive bladder cancer
Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared a post on X about…
Sep 11, 2024, 16:30 | Blog
Idalid Franco: Prepping for upcoming activities
Idalid Franco shared a post on X: Prepping for upcoming activities "American Society for Radiation…
Sep 11, 2024, 16:20 | Blog
Kimryn Rathmell: AllofUsResearch - Changing the future of health research
Kimryn Rathmell shared a post by AllofUsResearch on X, adding: "Exciting to see this AllofUsResearch…
Sep 11, 2024, 16:13 | Insight
RYBREVANT plus LAZCLUZE versus osimertinib in EGFR-mutated advanced lung cancer
New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT plus LAZCLUZE regimen compared…
Sep 11, 2024, 15:45 | Blog
Catherine Mwaba: Serving on the AORTIC Council as VP of Southern Africa is a privilege
Catherine Mwaba, Head of the Radiation and Clinical Oncology Section at Cancer Diseases Hospital, shared…
Sep 11, 2024, 14:46 | OncoDaily Pulse
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
OncoDaily is pleased to announce a strategic partnership with the Asian Fund for Cancer Research…
Sep 11, 2024, 13:57 | Blog
Melvin LK Chua on the individualization of systemic therapies with radiotherapy in NPC at ESMO24
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Sep 11, 2024, 13:56 | Blog
Estela Rodriguez: Celebrating 50 years of IASLC
Estela Rodriguez shared a post on X: ''Celebrating 50 years of IASLC building community, friendships, collaboration…
Sep 11, 2024, 13:55 | Blog
Ana I. Velazquez Manana: Who benefits from adjuvant immunotherapy after neoadjuvant chemotherapy plus immunotherapy and surgery
Ana I. Velazquez Manana shared a post on X: ''Exploratory analysis comparing CM816 to CM77T…
All: 70 Posts: 21 - 30
Special Coverage